PaceMate is an automated cardiac data management platform for patients with cardiac implantable devices such as pacemakers, cardioverter-defibrillators, or other wearable devices. The company provides real-time remote patient monitoring services for healthcare providers by uploading device-generated data onto the platform, providing customized alerts, and offering automated billing codes for reimbursements together with electronic health record vendors.
The company’s in-house, proprietary technology automatically manages heart failure metrics and helps healthcare providers identify worsening symptoms of patients to enable early intervention. The company’s additional on-demand service provides customized clinical staffing assistance and clinical service options including 24/7 or after-hours continuous patient monitoring support from specialists in cardiac rhythm management.
Funding and financials
In July 2023, the company received an undisclosed strategic growth investment from technology-focused investment fund Lead Edge Capital. The raised funds were set aside to scale the company’s market presence, expand its product portfolio, and provide its solutions to more healthcare providers.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.